{
  "id": 10961268,
  "title": "Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial",
  "url": "https://urgent.news/2026/09/30/eli-lilly-says-closely-watched-combo-obesity-regimen-boosts-weight",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-30T14:32:03.000Z",
  "source": {
    "name": "CNBC",
    "slug": "cnbc",
    "url": "https://www.cnbc.com/2026/09/30/eli-lilly-obesity-drug-amylin-tirzepatide-weight-loss-trial.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "Lilly said it plans to start Phase 3 trials on the combo regimen adding its amylin drug eloralintide to tirzepatide at the end of the year.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "Quartz",
        "title": "Eli Lilly's experimental weight loss drug shed 21% of body weight in diabetes trial",
        "url": "https://urgent.news/2026/09/30/eli-lillys-experimental-weight-loss-drug-shed-21-of-body-weight-in",
        "published": "2026-09-30T12:10:35.000Z"
      },
      {
        "outlet": "CNBC World",
        "title": "Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial",
        "url": "https://urgent.news/2026/09/30/eli-lilly-says-closely-watched-combo-obesity-regimen-boosts-weight-10961289",
        "published": "2026-09-30T14:32:03.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}